www.sfgate.com

www.sfgate.com
Share

www.sfgate.com

 •  November 9, 2017

TRENTON, N.J. (AP) — In a story Nov. 8 about a new drug approval, The Associated Press misspelled the drug's name. It is Prevymis, not Prevymix. A corrected version of the story is below: FDA OKs drug to block infection after marrow transplant U.S. regulators approve new drug to prevent life-threatening infections in adults after a bone marrow...

www.sfgate.com

 •  October 27, 2017

SAN FRANCISCO (BCN) Two organizations in the San Francisco Bay Area and two outside have come together to cut the time it takes to discover cancer drugs from about six years to one, officials with the consortium said today. The effort, which launched today, brings together experts in drug discovery at the University of California at San Francisco,...

www.sfgate.com

 •  October 26, 2017

COLUMBUS, Ohio (AP) — Backers of a fall ballot issue in Ohio aimed at lowering what the state pays for drugs have been outspent by the pharmaceutical industry-funded opposition by nearly 4-1. Campaign finance reports filed Thursday show Ohioans Against the Deceptive Rx Ballot Issue has spent $39.4 million against Issue 2 since July. It still has...

www.sfgate.com

 •  April 21, 2017

A drugmaker asked Arkansas officials not to purchase its products for executions months before the state accepted a third-party "donation" of potassium chloride as one of three drugs to use in lethal injections, according to letters obtained by The Associated Press. Fresenius Kabi USA wrote to Department of Correction Director Wendy Kelley and...

www.sfgate.com

 •  March 7, 2017

Up went the tweet, and down went drug company stocks. Just before the stock market opened on Tuesday, President Trump said he is working on “a new system” to reduce prices. He also said he’ll bring “competition” to the drug industry. It’s not the first time comments from Trump have had a big effect on pharmaceutical stocks: He hasn’t gotten into...

www.sfgate.com

 •  February 14, 2017

(04-23) 17:46 PDT San Francisco -- A cure for hepatitis C might seem like welcome news in India, where 12 million people suffer from the disease. But the country isn't quite rolling out the red carpet for Sovaldi, the breakthrough drug by Gilead Sciences in Foster City. Sovaldi is already controversial in the United States, where insurers,...

www.sfgate.com

 •  February 14, 2017

AbbVie Inc. appears to be on the verge of a $53.7 billion takeover that would change its corporate address to the United Kingdom. Abbott Laboratories agreed Monday to sell part of its generic drug business for $5.3 billion, structuring the sale in a way that opens the door for the buyer to reincorporate in Europe. Baxter International Inc. is...